Cochrane Abstracts
Neoadjuvant chemotherapy or chemoradiotherapy versus upfront surgery alone for resectable or borderline resectable pancreatic cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Upfront Surgery Alone for Resectable or Borderline Resectable Pancreatic Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432274/all/Neoadjuvant_chemotherapy_or_chemoradiotherapy_versus_upfront_surgery_alone_for_resectable_or_borderline_resectable_pancreatic_cancer.
Neoadjuvant chemotherapy or chemoradiotherapy versus upfront surgery alone for resectable or borderline resectable pancreatic cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432274/all/Neoadjuvant_chemotherapy_or_chemoradiotherapy_versus_upfront_surgery_alone_for_resectable_or_borderline_resectable_pancreatic_cancer. Accessed January 25, 2025.
Neoadjuvant chemotherapy or chemoradiotherapy versus upfront surgery alone for resectable or borderline resectable pancreatic cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432274/all/Neoadjuvant_chemotherapy_or_chemoradiotherapy_versus_upfront_surgery_alone_for_resectable_or_borderline_resectable_pancreatic_cancer
Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Upfront Surgery Alone for Resectable or Borderline Resectable Pancreatic Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432274/all/Neoadjuvant_chemotherapy_or_chemoradiotherapy_versus_upfront_surgery_alone_for_resectable_or_borderline_resectable_pancreatic_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Neoadjuvant chemotherapy or chemoradiotherapy versus upfront surgery alone for resectable or borderline resectable pancreatic cancer
ID - 432274
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432274/all/Neoadjuvant_chemotherapy_or_chemoradiotherapy_versus_upfront_surgery_alone_for_resectable_or_borderline_resectable_pancreatic_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
